← Back to headlines
Argenx SE to Showcase Vyvgart's Efficacy in Broader Autoimmune Diseases
Argenx SE is preparing to present evidence of its drug Vyvgart's effectiveness across a wider spectrum of autoimmune diseases, potentially expanding its therapeutic applications.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Climate Catastrophes in Europe Cost Billions, Burdening Citizens
25m ago
Former Google CEO Eric Schmidt Selling Superyacht for €149 Million
26m ago
Berkshire Hathaway's Significant Investment in Alphabet Stock
33m ago
Fabrinet Shares Decline Despite Earnings Beat Due to Margin and Cash Flow Concerns
49m ago